Published in Biomed Res Int on February 14, 2017
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis (2003) 16.18
Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant (2003) 6.15
Bone formation and inflammation in cardiac valves. Circulation (2001) 6.01
Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest (1993) 4.54
Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int (2002) 4.38
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int (2005) 3.71
The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant (2010) 3.10
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol (2008) 2.96
Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis (2011) 2.88
Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? Clin J Am Soc Nephrol (2009) 2.81
Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis (1999) 2.56
Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation (2001) 2.55
Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol (1998) 2.49
New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis (1997) 2.45
Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. Circulation (2008) 2.44
A single-dose study of denosumab in patients with various degrees of renal impairment. J Bone Miner Res (2012) 2.43
Sudden and cardiac death rates in hemodialysis patients. Kidney Int (1999) 2.27
Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis (2004) 2.15
Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int (2002) 2.03
Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin J Am Soc Nephrol (2008) 1.97
Sodium thiosulfate therapy for calcific uremic arteriolopathy. Clin J Am Soc Nephrol (2013) 1.97
Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int (2006) 1.96
Uremia-related vascular calcification: more than apatite deposition. Kidney Int (2006) 1.84
Progression of coronary artery calcification and thoracic aorta calcification in kidney transplant recipients. Am J Kidney Dis (2011) 1.74
Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial (2002) 1.67
Arterial calcification and bone physiology: role of the bone-vascular axis. Nat Rev Endocrinol (2012) 1.66
Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine (2004) 1.64
Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol (2003) 1.63
Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood (2007) 1.62
Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. Eur Heart J (2011) 1.60
Hidden sources of phosphorus in the typical American diet: does it matter in nephrology? Semin Dial (2003) 1.60
Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease. Kidney Int (2011) 1.58
Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis. Am J Kidney Dis (2015) 1.58
The effect of a high intake of calcium carbonate in normal subjects and patients with chronic renal failure. Clin Sci (1966) 1.50
Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD. J Am Soc Nephrol (2014) 1.50
The case for routine parathyroid hormone monitoring. Clin J Am Soc Nephrol (2012) 1.43
A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant (2004) 1.42
Severe hypocalcemia following denosumab injection in a hemodialysis patient. Am J Kidney Dis (2012) 1.41
Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice. J Biol Chem (2003) 1.40
Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol (2008) 1.35
Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients. Ther Apher Dial (2008) 1.31
Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am J Clin Nutr (2009) 1.24
Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice. Am J Pathol (2009) 1.23
Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients. Nephrol Dial Transplant (1996) 1.21
Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension (2006) 1.17
Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J Bone Miner Res (2005) 1.16
Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis. Nephrol Dial Transplant (2006) 1.15
Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study. Nephrol Dial Transplant (2009) 1.14
Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol (1996) 1.13
Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol (2001) 1.09
Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure. Nephrol Dial Transplant (2004) 1.09
Cardiovascular risk in uraemic patients-is it fully explained by classical risk factors? Nephrol Dial Transplant (2000) 1.09
Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int (1999) 1.08
Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease. Clin J Am Soc Nephrol (2012) 1.05
Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD. Am J Kidney Dis (2005) 1.05
Differences in bone quality in low- and high-turnover renal osteodystrophy. J Am Soc Nephrol (2011) 1.05
An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis (2003) 1.05
Effect of ultrapure dialysate on markers of inflammation, oxidative stress, nutrition and anemia parameters: a meta-analysis. Nephrol Dial Transplant (2013) 1.01
Dietary phosphate restriction and protein intake in dialysis patients: a misdirected focus. Semin Dial (2007) 1.01
Regression of vascular calcification following an acute episode of calciphylaxis: a case report. J Med Case Rep (2014) 1.00
Calciphylaxis responding to sodium thiosulfate therapy. Arch Dermatol (2007) 0.96
Long-term effects of high-efficiency on-line haemodiafiltration on uraemic toxicity. A multicentre prospective randomized study. Nephrol Dial Transplant (2011) 0.96
Progression of coronary artery calcification in renal transplantation and the role of secondary hyperparathyroidism and inflammation. Clin J Am Soc Nephrol (2009) 0.95
What serum calcium can tell us and what it can't. Nephrol Dial Transplant (2005) 0.94
Anti-sclerostin antibody and mechanical loading appear to influence metaphyseal bone independently in rats. Acta Orthop (2011) 0.94
Sodium thiosulfate as first-line treatment for calciphylaxis. Arch Dermatol (2007) 0.94
Phosphate elimination in modalities of hemodialysis and peritoneal dialysis. Blood Purif (2010) 0.93
Adynamic bone disease: from bone to vessels in chronic kidney disease. Semin Nephrol (2014) 0.92
Simple evaluation of aortic arch calcification by chest radiography in hemodialysis patients. Hemodial Int (2009) 0.91
Effect of the hemodialysis membrane on the inflammatory reaction in vivo. Clin Nephrol (2000) 0.90
Tumoral calcinosis in patients on hemodialysis. Case report and review of the literature. Am J Nephrol (1997) 0.90
The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis. Clin Biochem (2012) 0.90
The effect of dialysis modality on phosphate control : haemodialysis compared to haemodiafiltration. The Pan Thames Renal Audit. Nephrol Dial Transplant (2009) 0.88
Reduction of Dialysate Calcium Level Reduces Progression of Coronary Artery Calcification and Improves Low Bone Turnover in Patients on Hemodialysis. J Am Soc Nephrol (2015) 0.87
Patient mortality and survival. United States Renal Data System. Am J Kidney Dis (1998) 0.86
Progression of coronary artery calcification in renal transplant recipients. Nephrol Dial Transplant (2011) 0.86
Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice? BMC Nephrol (2011) 0.86
Optimizing the dialysate calcium concentration in bicarbonate haemodialysis. Nephrol Dial Transplant (2012) 0.85
The Labile Side of Iron Supplementation in CKD. J Am Soc Nephrol (2015) 0.85
Advanced mitral annular calcification is associated with severe coronary calcification on fast dual spiral computed tomography. Invest Radiol (2000) 0.84
Complete resorption of massive soft tissue calcification in a hemodialysis patient after parathyroidectomy. Am J Nephrol (2000) 0.82
Pleiotropic effects of sevelamer beyond phosphate binding in end-stage renal disease patients: a randomized, open-label, parallel-group study. Clin Drug Investig (2011) 0.82
Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients. Nephrol Dial Transplant (2011) 0.81
Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients. Am J Kidney Dis (2004) 0.81
Hyperphosphatemia in Dialysis Patients: Beyond Nonadherence to Diet and Binders. Am J Kidney Dis (2015) 0.80
Serum fetuin-A levels increased following parathyroidectomy in uremic hyperparathyroidism. Clin Nephrol (2012) 0.79
Association between increased serum osteoprotegerin levels and improvement in bone mineral density after parathyroidectomy in hemodialysis patients. Tohoku J Exp Med (2012) 0.79
Vitamin K antagonists predispose to calciphylaxis in patients with end-stage renal disease. Nephron (2015) 0.79
Fetuin-A decrease induced by a low-protein diet enhances vascular calcification in uremic rats with hyperphosphatemia. Am J Physiol Renal Physiol (2015) 0.79
Calcium mass balances in bicarbonate hemodialysis. Int J Nephrol (2011) 0.79
Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study. J Clin Endocrinol Metab (2016) 0.78
High cut-off dialysis in chronic haemodialysis patients reduces serum procalcific activity. Nephrol Dial Transplant (2016) 0.78
Vitamin D and secreted Klotho: a long-awaited panacea for vascular calcification? Kidney Int (2012) 0.77
Advances in pharmacotherapy for hyperphosphatemia in renal disease. Expert Opin Pharmacother (2015) 0.77
Beneficial effects of selective vitamin D receptor activation by paricalcitol in chronic kidney disease. Curr Drug Targets (2014) 0.76
An open-label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis. J Clin Endocrinol Metab (2014) 0.76
Regression of vascular calcification in a parathyroidectomized patient on dialysis with untreated hypocalcemia over 12-year follow-up . Clin Nephrol (2016) 0.75